(Press-News.org) Putnam Valley, NY. (June 26 , 2012) –Researchers in Japan who evaluated the risks and efficacy of transplanting two varieties of stem cells into mouse cochlea have concluded that both adult-derived induced pluripotent stem (iPS) cells and mouse embryonic stem (ES) cells demonstrate similar survival and neural differentiation capabilities. However, there is a risk of tumor growth associated with transplanting iPS cells into mouse cochleae. Given the potential for tumorigenesis, they concluded that the source of iPS cells is a critical issue for iPS cell-based therapy.
Their study is published in a recent issue of Cell Transplantation (21:4), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/,
"Hearing loss affects millions of people worldwide," said Dr. Takayuki Nakagawa of the Department of Otolaryngology, Graduate School of Medicine, Kyoto University, Japan. "Recent studies have indicated the potential of stem-cell based approaches for the regeneration of hair cells and associated auditory primary neurons. These structures are essential for hearing and defects result in profound hearing loss and deafness."
The authors noted that embryonic stem cells have previously been identified as promising candidates for transplantation, however they have also been associated with immune rejection and ethics issues. Consequently, this study compared the survival and neural differentiation capabilities of ES and three clones of mouse iPS cells.
"Our study examined using induced pluripotent stem cells generated from the patient source to determine if they offer a promising alternative to ES cells," explained Dr. Nakagawa. "In addition, the potential for tumor risk from iPS cells needed clarification."
Four weeks after transplantation, the researchers found that the majority of cochleae that had been transplanted exhibited the settlement of iPS or ES-derived neurons. However, there was a difference in the number of cells present based on cell lines. They noted that the number of cells able to be transplanted into cochleae is limited because of the cochleae's tiny size. Thus, the number of settled cells is low.
They also noted the formation of a teratoma (encapsulated tumor) in some cochlea after transplantation with one group of iPS cells.
"To our knowledge, this is the first documentation of teratoma formation in cochleae after cell transplantation," said Dr. Nakagawa.
The researchers concluded that the teratoma formation in one iPS cell line indicated the necessity for selecting appropriate iPS cell lines for avoiding tumorigenesis. They also noted the need for developing methods to eliminate undifferentiated cells after neural induction in order to establish safe iPS-based therapy for the inner ear.
"While this study did not look at the ability of the transplanted cells to repair hearing loss, it does provide insight into the survival and fate of transplanted cells. It highlights the importance of factors such as knowing the original source of the cells and their degree of undifferentiation to enable the cells to be ranked in order of their likelihood of forming tumors" said Dr. John Sladek, professor of neurology and pediatrics at the University of Colorado School of Medicine.
###
Contact: Takayuki Nakagawa, MD, PhD, Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kawahara-cho 54, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
Tel. +81-75-751-3346
Fax. +81-75-751-7225
Email tnkagawa@ent.kuhp.kyoto-u.ac.jp
Citation: Nishimura, K.; Nakagawa, T.; Sakamoto, T.; Ito, J. Fates of murine pluripotent stem
cell-derived neural progenitors following transplantation into mouse cochleae. Cell Transplant. 21(4):763-771; 2012.
The Coeditor-in-chief's for CELL TRANSPLANTATION are at the Diabetes Research Institute, University of Miami Miller School of Medicine and Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact, Camillo Ricordi, MD at ricordi@miami.edu or Shinn-Zong Lin, MD, PhD at shinnzong@yahoo.com.tw or David Eve, PhD at celltransplantation@gmail.com
Stem cell transplantation into mouse cochlea may impact future hearing loss therapies
2012-06-27
ELSE PRESS RELEASES FROM THIS DATE:
Study suggests touch therapy helps reduce pain, nausea in cancer patients
2012-06-27
LEXINGTON, Ky. (June 26, 2012) — A new study by the University of Kentucky Markey Cancer Center shows that patients reported significant improvement in side effects of cancer treatment following just one Jin Shin Jyutsu session. Jin Shin Jyutsu is an ancient form of touch therapy similar to acupuncture in philosophy.
Presented at the 2012 Markey Cancer Center Research Day by Jennifer Bradley who is the Jin Shin Jyutsu integrative practitioner at Markey, the study included 159 current cancer patients. Before and after each Jin Shin Jyutsu session, Bradley asked patients ...
US mammograms decline after task force recommendation, Mayo Clinic finds
2012-06-27
ROCHESTER, Minn. -- Preventive mammography rates in women in their 40s have dropped nearly 6 percent nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, a Mayo Clinic analysis shows. That represents a small but significant decrease since the controversial guidelines were released, the researchers say. Their findings are being presented at the Academy Health Annual Research Meeting, June 24-26, in Orlando, Fla.
"The 2009 USPSTF guidelines resulted in significant backlash among patients, physicians ...
Musical robot companion enhances listener experience
2012-06-27
Wedding DJs everywhere should be worried about job security now that a new robot is on the scene.
Shimi, a musical companion developed by Georgia Tech's Center for Music Technology, recommends songs, dances to the beat and keeps the music pumping based on listener feedback.
The smartphone-enabled, one-foot-tall robot is billed as an interactive "musical buddy."
"Shimi is designed to change the way that people enjoy and think about their music," said Professor Gil Weinberg, director of Georgia Tech's Center for Music Technology and the robot's creator.
He will ...
Lab-on-a-chip detects trace levels of toxic vapors in homes near Utah Air Force Base
2012-06-27
ANN ARBOR, Mich.---A lab-on-a-chip technology that measures trace amounts of air contaminants in homes was successfully field-tested by researchers at the University of Michigan.
Even in the presence of 50 other indoor air contaminants, the U-M-built microsystem found levels of the targeted contaminant so low that it would be analogous to finding a particular silver dollar in a roll stretching from Detroit to Salt Lake City.
"This is the first (known) study of its kind," said Ted Zellers, professor in the U-M School of Public Health and the Department of Chemistry, ...
NASA satellite spots newborn Tropical Depression Doksuri in W. Pacific
2012-06-27
Another tropical depression was born in the western North Pacific, and NASA's Terra satellite captured an infrared image of the newborn cyclone. Tropical depression Doksuri, known in the Philippines as Dindo, was born during the early hours of June 26, 2012 in the western North Pacific Ocean.
The Moderate Imaging Spectroradiometer (MODIS) instrument onboard NASA's Terra satellite as captured an infrared image of the newborn storm on June 26 at 0228 UTC. The image revealed higher thunderstorms around the center of Tropical Depression Doksuri that were casting shadows on ...
NASA satellites see wildfires across Colorado
2012-06-27
Nearly half of the United States' airborne fire suppression equipment was operating over Colorado on June 25, 2012, CNN reported, as tens of thousands of acres burned. Fires raged in southwestern Colorado, northeastern Colorado, and multiple locations in between.
The Moderate Resolution Imaging Spectroradiometer (MODIS) on NASA's Aqua satellite captured this natural-color image on June 23, 2012. Red outlines approximate the locations of actively burning fires. The High Park and Weber Fires produced the largest plumes of smoke.
The High Park Fire continued to burn west ...
UMass Medical School researchers discover a new role for RNAi
2012-06-27
WORCESTER, MA – Organisms employ a fascinating array of strategies to identify and restrain invasive pieces of foreign DNA, such as those introduced by viruses. For example, many viruses produce double-stranded (ds)RNA during their life cycle and the RNA interference (RNAi) mechanism is thought to recognize this structural feature to initiate a silencing response.
Now, UMass Medical School researchers have identified a mechanism related to RNAi that scans for intruders not by recognizing dsRNA or some other aberrant feature of the foreign sequence, but rather by comparing ...
NASA's Hubble spots rare gravitational arc from distant, hefty galaxy cluster
2012-06-27
Seeing is believing, except when you don't believe what you see.
Astronomers using NASA's Hubble Space Telescope have found a puzzling arc of light behind an extremely massive cluster of galaxies residing 10 billion light-years away. The galactic grouping, discovered by NASA's Spitzer Space Telescope, was observed when the universe was roughly a quarter of its current age of 13.7 billion years. The giant arc is the stretched shape of a more distant galaxy whose light is distorted by the monster cluster's powerful gravity, an effect called gravitational lensing.
The ...
New mouse model helps explain gene discovery in congenital heart disease
2012-06-27
Scientists now have clues to how a gene mutation discovered in families affected with congenital heart disease leads to underdevelopment of the walls that separate the heart into four chambers. A Nationwide Children's Hospital study appearing in PLoS Genetics suggests that abnormal development of heart cells during embryogenesis may be to blame.
When babies are born with a hole in their heart (either between the upper or lower chambers), they have a septal defect, the most common form of congenital heart disease. Although it's not clear what causes all septal defects, ...
Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
2012-06-27
Richmond, Va. (June 22, 2012) – A recent Phase I/II clinical trial has shown that a new combination of radiation therapies developed at Virginia Commonwealth University Massey Cancer Center escalates radiation doses to safely and effectively treat prostate cancer and lower the risk of recurrence with minimal radiation exposure to nearby healthy tissue and organs.
Recently published in the journal Brachytherapy, a novel treatment protocol designed by Michael Hagan, M.D., Ph.D., radiation oncologist at VCU Massey Cancer Center, that combines intensity-modulated radiation ...